PHYTOMAB Trademark

Trademark Overview


On Tuesday, April 6, 2021, a trademark application was filed for PHYTOMAB with the United States Patent and Trademark Office. The USPTO has given the PHYTOMAB trademark a serial number of 79313411. The federal status of this trademark filing is REGISTERED as of Tuesday, August 9, 2022. This trademark is owned by PHYTOMAB CO., LTD.. The PHYTOMAB trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Medicines for the treatment of cancer, namely, anticancer medicines; biological preparations for medical, pharmaceutical and veterinary purposes, namely, biological preparations for treatment of cancer; proteins for medical, pharmaceutical and veterinary purposes, namely, protein arrays for medical diagnosis purposes; biological vectors for medical, pharmaceutical and veterinary purposes, namely, viral vectors for treatment of cancer; [ preparations of transformation microorganisms for medical, pharmaceutical and veterinary purposes, namely, for the treatment of cancer; preparations of microorganisms for medical, pharmaceutical and veterinary purposes used for enhancing biomolecule production for treating cancer; ] preparations of gene recombination for medical, pharmaceutical and veterinary purposes used for biomolecule production for treating cancer; recombinant cells for medical, pharmaceutical and veterinary purposes; cell lines for medical, pharmaceutical and veterinary purposes; ...

[ pharmaceutical research and development; ] chemistry services, namely, chemical analysis; synthetic biology services, namely, research and analysis in the field of synthetic biology; stem cells biology services, namely, research and analysis in the field of stem cell biology; Stem cell research services; drug discovery services using plant cells; drug discovery services using stem cells; development services of new pharmaceutical products; [ laboratory research services relating to pharmaceuticals; ] testing of pharmaceuticals; medical research; biotechnological research; biological research; chemical research; research and development services relating to genetic testing; research and development services relating to medical, pharmacological and veterinary science; laboratory research in the field of pharmaceuticals, biology, biochemistry and chemistry; research and development services in the field of [ microorganisms and ] cells technology; research services in the field of chemis...
phytomab

General Information


Serial Number79313411
Word MarkPHYTOMAB
Filing DateTuesday, April 6, 2021
Status700 - REGISTERED
Status DateTuesday, August 9, 2022
Registration Number6810859
Registration DateTuesday, August 9, 2022
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 24, 2022

Trademark Statements


Description of MarkThe mark consists of the word "PHYTOMAB" colored blue. The figures of split leaf consist of right upper part gradated green to light green and left lower part gradated blue to light blue. The color white appears along the line of leaf veins.
Certificate of Correction for RegistrationIn the statement, classes 5 and 42 have been corrected per the Restriction dated 01/26/2023 and the Fnote dated 05/03/2023.
Goods and ServicesMedicines for the treatment of cancer, namely, anticancer medicines; biological preparations for medical, pharmaceutical and veterinary purposes, namely, biological preparations for treatment of cancer; proteins for medical, pharmaceutical and veterinary purposes, namely, protein arrays for medical diagnosis purposes; biological vectors for medical, pharmaceutical and veterinary purposes, namely, viral vectors for treatment of cancer; [ preparations of transformation microorganisms for medical, pharmaceutical and veterinary purposes, namely, for the treatment of cancer; preparations of microorganisms for medical, pharmaceutical and veterinary purposes used for enhancing biomolecule production for treating cancer; ] preparations of gene recombination for medical, pharmaceutical and veterinary purposes used for biomolecule production for treating cancer; recombinant cells for medical, pharmaceutical and veterinary purposes; cell lines for medical, pharmaceutical and veterinary purposes; medical, pharmaceutical and veterinary preparations for the treatment of cells; stem cells for medical, pharmaceutical and veterinary purposes; vaccines for medical, pharmaceutical and veterinary purposes; antibiotics for medical, pharmaceutical and veterinary purposes; anti-cancer preparations for medical, pharmaceutical and veterinary purposes; nucleic acid sequences for medical, pharmaceutical and veterinary purposes; biopharmaceuticals for treatment of hepatitis; biopharmaceuticals for the treatment of cancer; biopharmaceuticals for the treatment of auto-immune diseases
Indication of Colors claimedThe color(s) blue, green, light green, light blue, white is/are claimed as a feature of the mark.
Goods and Services[ pharmaceutical research and development; ] chemistry services, namely, chemical analysis; synthetic biology services, namely, research and analysis in the field of synthetic biology; stem cells biology services, namely, research and analysis in the field of stem cell biology; Stem cell research services; drug discovery services using plant cells; drug discovery services using stem cells; development services of new pharmaceutical products; [ laboratory research services relating to pharmaceuticals; ] testing of pharmaceuticals; medical research; biotechnological research; biological research; chemical research; research and development services relating to genetic testing; research and development services relating to medical, pharmacological and veterinary science; laboratory research in the field of pharmaceuticals, biology, biochemistry and chemistry; research and development services in the field of [ microorganisms and ] cells technology; research services in the field of chemistry, biochemistry, enzymology, biology, cell biology and biotechnology

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 22, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, June 22, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePHYTOMAB CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR

Party NamePHYTOMAB CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR

Party NamePHYTOMAB CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Saturday, January 13, 2024INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Wednesday, January 3, 2024PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Thursday, June 8, 2023NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, June 6, 2023NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Wednesday, May 3, 2023LIMITATION FROM THE IB EXAMINED AND ENTERED
Wednesday, May 3, 2023CORRECTION UNDER SECTION 7 - PROCESSED
Monday, February 6, 2023LIMITATION OF GOODS RECEIVED FROM IB
Monday, December 12, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, November 18, 2022FINAL DISPOSITION NOTICE SENT TO IB
Friday, November 18, 2022FINAL DISPOSITION PROCESSED
Wednesday, November 9, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 9, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 9, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, May 24, 2022NOTIFICATION PROCESSED BY IB
Tuesday, May 24, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 24, 2022PUBLISHED FOR OPPOSITION
Wednesday, May 4, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, May 4, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, May 4, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, April 16, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 6, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 6, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 6, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 6, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 6, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 6, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 6, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 6, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, January 15, 2022REFUSAL PROCESSED BY IB
Monday, December 27, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, December 27, 2021REFUSAL PROCESSED BY MPU
Tuesday, November 30, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, November 29, 2021NON-FINAL ACTION WRITTEN
Monday, November 22, 2021ASSIGNED TO EXAMINER
Saturday, June 26, 2021APPLICATION FILING RECEIPT MAILED
Tuesday, June 22, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 17, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB